文献速递冠心病外科

冠状动脉旁路移植术中序贯与单支大隐静脉桥血管的比较

Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery.
PubMed 文献 · Ann Thorac Surg · 2019-09-17

结果显示两种技术在死亡及复合终点上无显著差异,但序贯移植的桥血管通畅率优于单支移植。

要点

  • 序贯与单支大隐静脉桥在死亡及复合终点上无显著差异
  • 序贯移植的长期桥血管通畅率优于单支移植
  • 在某些临床情况下序贯大隐静脉桥可作为第二根桥血管的合理选择

核心结论

  • 序贯大隐静脉桥血管移植安全有效,长期通畅率优于单支移植,在某些临床情况下可作为冠状动脉旁路移植术中第二根桥血管的合理选择。

研究设计与样本

  • 共纳入2515例符合条件的患者,其中序贯组1037例(41.3%),单支组1478例(58.8%)。
  • 采用倾向性评分匹配比较两组临床结局与桥血管通畅率,最终分析纳入901对匹配患者和891对匹配桥血管。
  • 桥血管通畅率通过冠状动脉计算机断层扫描血管造影评估。

主要发现

  • 未校正总死亡率两组差异无统计学意义(P = .83)。
  • 校正后总死亡率两组差异无统计学意义(风险比[HR] 0.96,95%置信区间[CI] 0.79至1.17,P = .67)。
  • 死亡、非致死性心肌梗死与再次血运重建的复合终点在匹配前(P = .20)与匹配后(HR 0.91,95%CI 0.75至1.09,P = .30)均无显著差异。
  • 序贯移植的桥血管通畅率优于单支移植,匹配前(P = .015)与校正后(HR 0.61,95%CI 0.45至0.82,P < .001)均显著。

临床怎么用

  • 在冠状动脉旁路移植术中使用大隐静脉桥血管时,序贯吻合技术安全可行且长期通畅率更优。
  • 在某些临床情况下,可将序贯大隐静脉桥作为第二根桥血管的合理选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although multiarterial grafting or bilateral mammary artery use is being increasingly emphasized for contemporary coronary artery bypass grafting (CABG) practice, saphenous vein graft (SVG) is still the most frequently used CABG conduit, and it accounts for 80% of all CABG conduits. Research focusing on modifiable surgical factors such as anastomosis technique, however, is scarce. This study aimed to compare clinical outcomes and graft patency according to anastomosis methods of vein grafting. METHODS: From January 2005 through December 2016, patients who underwent CABG using SVG either by a sequential or an individual grafting technique were enrolled in this study. Graft patency was evaluated with coronary computed tomographic angiography. Propensity-score matching was used to compare the clinical outcomes and graft patency of these 2 grafting techniques to reduce treatment selection bias. RESULTS: Overall 2515 eligible patients, 1,037 in the sequential SVG graft group (41.3%) and 1478 (58.8%) in the individual SVG graft group were enrolled. After propensity-score matching, 901 matched pairs of patients and 891 matched pairs of grafts were included in the final outcome analysis. There were no significant differences in unadjusted (P = .83) and adjusted overall mortality (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.79 to 1.17; P = .67). The composite outcome of death, nonfatal myocardial infarction, and repeat revascularization also did not significantly differ between the sequential SVG and the individual SVG groups for both before (P = .20) and after matching (HR, 0.91; 95% CI, 0.75 to 1.09; P = .30). The sequential grafts showed superior patency as compared with the individual grafts for both before (P = .015) and after adjustment (HR, 0.61; 95% CI, 0.45 to 0.82; P < .001). CONCLUSIONS: The sequential grafting technique of SVG showed fairly acceptable safety and efficacy with superior long-term graft patency than individual grafts. Sequential SVG grafts perhaps can be a reasonable option as a second graft in CABG in some clinical situations.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Park SJ, Kim HJ, Kim JB, et al. Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery. Ann Thorac Surg. 2019. PMID: 31539513. doi:10.1016/j.athoracsur.2019.07.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。